114(top 2%)
papers
11.7K(top 1%)
citations
55(top 1%)
h-index
113(top 1%)
g-index
135
all documents
14.3K
doc citations
2.1K
citing journals

Top Articles

#TitleJournalYearCitations
1Lung cancer: current therapies and new targeted treatmentsLancet, The20172,436
2PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison ProjectJournal of Thoracic Oncology20171,100
3Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung CancerJournal of Thoracic Oncology2012599
4Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell CarcinomasJournal of Clinical Oncology2006538
5Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer PatientsJournal of Clinical Oncology2009535
6New and emerging targeted treatments in advanced non-small-cell lung cancerLancet, The2016396
7IncreasedHER2Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer PatientsJournal of Clinical Oncology2005368
8PD-L1 Expression in Lung CancerJournal of Thoracic Oncology2016366
9Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.Journal of Clinical Investigation1997293
10High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung CancerJournal of Clinical Oncology2002264
11Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerCancer Immunology Research2019237
12The E-cadherin cell–cell adhesion complex and lung cancer invasion, metastasis, and prognosisLung Cancer2002215
13Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung CancerCancer Discovery2013204
14Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapiesLung Cancer2003189
15Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studiesEuropean Journal of Cancer2013153
16HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary TumorsClinical Cancer Research2009151
17Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancerOncotarget2015147
18Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid CancerJournal of Clinical Endocrinology and Metabolism2016145
19Tumor-Associated Lymphocytes and Increased FoxP3+ Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid CancerJournal of Clinical Endocrinology and Metabolism2010138
20Characteristics of Lung Cancers Harboring NRAS MutationsClinical Cancer Research2013135
21Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanomaMelanoma Research2017125
22Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?Archives of Pathology and Laboratory Medicine2016119
23Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012Journal of Thoracic Oncology2013115
24Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissueMolecular Carcinogenesis2006113
25Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancerBritish Journal of Cancer2012110
26Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology SocietyArchives of Pathology and Laboratory Medicine2016107
27Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology SocietyArchives of Pathology and Laboratory Medicine2016100
28Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4–anaplastic lymphoma kinase gene fusionBlood200199
29Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancerMolecular Cancer201496
30The DNA-Bending Protein HMG-1 Enhances Progesterone Receptor Binding to Its Target DNA SequencesMolecular and Cellular Biology199494
31Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibAnnals of Oncology200693
32HER2/neu expression in malignant lung tumorsSeminars in Oncology200292
33Long-Term Dietary Habits Affect Soy Isoflavone Metabolism and Accumulation in Prostatic Fluid in Caucasian MenJournal of Nutrition200588
34PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid CancerCancer Immunology Research201588
35EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)Journal of Thoracic Oncology200786
36Genetic Abnormalities of the EGFR Pathway in African American Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology200986
37Population-Based Estimate of the Contribution of TP53 Mutations to Subgroups of Early-Onset Breast Cancer: Australian Breast Cancer Family StudyCancer Research201086
38Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung AdenocarcinomasCancer Prevention Research200884
39The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non–small cell lung cancerCancer201484
40Acquisition of p16INK4Aandp15INK4BGene Abnormalities Between Initial Diagnosis and Relapse in Children With Acute Lymphoblastic LeukemiaBlood199982
41Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancerCellular Oncology (Dordrecht)201380
42The Insulin-Like Growth Factor Pathway in Lung CancerJournal of Thoracic Oncology200878
43Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and PrognosisClinical Cancer Research201175
44HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patientsBritish Journal of Cancer200573
45Epidermal growth factor receptor immunohistochemistryCancer200870
46Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancerCancer201369
47Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology SocietyArchives of Pathology and Laboratory Medicine201668
48Canine sarcomas as a surrogate for the human disease201863
49Leveraging the immune system to treat advanced thyroid cancersLancet Diabetes and Endocrinology,the201762
50Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancerCurrent Opinion in Oncology200560